UV Clinical A/S: Financial statements 2020
CVR: 38401572
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
UV Clinical A/S (CVR 38401572) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -411,403 and a net result of DKK -1,149,248 compared with DKK -1,433,657 the year before. Equity in the 2020 report amounted to DKK -2,124,461. The company had 1 employee in the financial year.
- Gross Profit
- DKK -411,403
- Profit/Loss
- DKK -1,149,248
- Equity
- DKK -2,124,461
- Total Assets
- DKK 305,329
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -411K | -1.1M | -2.1M | 1 |
| 2019 | - | -577K | -1.4M | -975K | 1 |
| 2018 | - | 4K | -799K | -584K | 1 |
| 2017 | - | -376K | -1.1M | 215K | 1 |
Official annual report
How creditworthy is UV Clinical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 5, 2020, Gitte Jürgens is registered as adm. dir. of UV Clinical A/S.
As of September 15, 2020, Jimmy Bak is registered as director of UV Clinical A/S.
As of September 15, 2020, Leif Helth Jensen has stepped down as director of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2019. Gross profit came to DKK -576,665, and the net result was DKK -1,433,657.
As of July 14, 2020, Jan Friis Schack has joined the board of directors of UV Clinical A/S.
As of July 14, 2020, Brian Schebye has left the board of directors of UV Clinical A/S.
As of March 31, 2020, Leif Helth Jensen has left the board of directors of UV Clinical A/S.
About UV Clinical A/S
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.